mRNA-4157,Pembrolizumab
Moderna,Merck
['melanoma', 'pembro']
a clinical trial by 's dr. jeffrey weber shows that combining an experimental mrna vaccine with pembrolizumab which hasn't been widely tested in cancer treatment reduced melanoma recurrence or death by 44 percent. #asco23 learn more: 
The latest clinical news and research from experts at @nyulangone. Ranked #3 Best Hospital in the nation by U.S. News & World Report.